1. Introduction {#s0005}
===============

The *SCN1A* gene (MIM\#[182389](182389){#ir0010}), which encodes the alpha 1 subunit of the voltage-gated sodium channel, is the most clinically identified gene associated with epilepsy. The spectrum of epilepsy related to *SCN1A* mutation spans from milder phenotypes, such as genetic epilepsy with febrile seizures plus (GEFS +), to severe myoclonic epilepsy of infancy (SMEI), also known as Dravet syndrome ([@bb0080]). GEFS + is characterized by recurrent febrile seizure events beyond 5--6 years of age, even up to the teenage years, and can develop a number of afebrile heterogeneous seizure types with remission in adolescence ([@bb0145], [@bb0020]). Dravet syndrome is a deleterious forms of childhood epilepsy characterized by recurrent febrile and afebrile seizures in the first year, followed by multiple seizure types resistant to various antiepileptic drugs, as well as cognitive, behavioral, and motor impairment ([@bb0045]). Mutation of *SCN1A* has been detected in 60--80% of patients with Dravet syndrome and, in contrast, only 10% of patients with GEFS + ([@bb0015], [@bb0100], [@bb0150]).

Although it remains to be elucidated which modifying factors are responsible for the different phenotypes of *SCN1A* mutation-related epilepsy, ([@bb0015], [@bb0110], [@bb0210]) previously published reports are largely in agreement on the role of decreased excitability of GABAergic inhibitory interneurons leading to an imbalance between excitation and inhibition in a selective area of the brain as a pathogenesis of *SCN1A* mutation-related epilepsy ([@bb0205], [@bb0125], [@bb0025]). Although this altered synaptic activity might not be the only mechanism that shapes connectivity patterns in brain, it will change the pattern of refinement of activity dependent neural circuitry during brain development ([@bb0175], [@bb0075]). We hypothesized that there would be large-scale structural changes in the brains of patients with *SCN1A* mutation as the result of altered synaptic activities and brain development. However, few data are available on the neuroimaging and neuropathology of epileptic patients with *SCN1A* mutation. Previous studies were unable to find specific or consistent neuroimaging findings related to *SCN1A* mutation ([@bb0015], [@bb0085], [@bb0160], [@bb0115]). Furthermore, the majority of patients with *SCN1A* mutation exhibited no gross structural brain abnormalities with the exception of a few minor findings, including cerebral or cerebellar atrophy, cortical dysplasia, or hippocampal sclerosis ([@bb0015], [@bb0085], [@bb0160]). Therefore, quantitative neuroimaging approaches such as brain volumetry and cortical morphometry may be useful in assessing the structural changes which could not otherwise be seen by conventional brain magnetic resonance imaging (MRI), and in understanding the pathogenesis of *SCN1A* mutation. Herein, we compared brain volume and cortical morphology in patients with *SCN1A* mutation-positive epilepsy and healthy control group as well as analyzed differences in the developmental patterns of their brains.

2. Methods {#s0010}
==========

2.1. Subjects {#s0015}
-------------

Epileptic patients with *SCN1A* mutation were recruited from the pediatric neurology clinics of three medical centers in Korea: Asan Medical Center, Samsung Medical Center, and Seoul National University Children\'s Hospital. We included patients who satisfied the following inclusion criteria: (i) epilepsy diagnosed by a pediatric neurologist; (ii) genetically confirmed *SCN1A* mutation; (iii) normal brain MRI. All patients underwent brain MRI for the diagnostic evaluation of epilepsy, and all images were interpreted by one pediatric neuroradiologist (HM Yoon), who confirmed that the images were free of any brain abnormalities. We collected patients\' clinical information, including age, sex, seizure onset, seizure phenotype, occurrence of status epilepticus during follow-up, resistance to multiple antiepileptic drug, cognitive and behavioral outcome, and *SCN1A* mutation type.

For each patient, two healthy control subjects matched in age and gender and without alleged neurologic deficits were recruited. All MRIs of the controls were reviewed and interpreted as normal by the same pediatric neuroradiologist (HM Yoon). Our study protocol was approved by the Institutional Review Board of all participating institutions (Asan Medical Center, Samsung Medical Center, Seoul National University Children\'s Hospital).

2.2. MRI acquisition {#s0020}
--------------------

MRI scans were obtained on a Philips Achieva 3.0T scanner (Philips Healthcare, Eindhoven, The Netherlands) (*n* = 53) and Siemens MAGNETOM Verio 3.0T scanner (Siemens AG, Erlangen, Germany) (*n* = 10). Three-dimensional whole brain T1 sequence imaging was acquired with the following image parameters: echo time (TE) = 4.6 ms, repetition time (TR) = 9.8 ms, flip angle (FA) = 8.08, field of view (FOV) = 224 × 224 mm, matrix = 256 × 256, slice thickness = 1 mm, sagittal images of the entire brain with in-plane resolution 1.0 mm × 1.0 mm or TE = 5.1 ms, TR = 25 ms, FA = 30, FOV = 220 × 220 mm, matrix = 512 × 512, slice thickness = 1 mm, sagittal images of the entire brain with in-plane resolution 1.0 mm × 1.0 mm on a Philips 3.0 T Achieva scanner. On the MAGNETOM Verio scanner, images were obtained with TE = 1.9 ms, TR = 1500 ms, FA = 9.0, FOV = 220 × 220 mm, matrix = 256 × 256, slice thickness = 1 mm, sagittal images of the entire brain with in-plane resolution 1.0 mm × 1.0 mm. Before data processing, all raw T1 sequencing images were visually inspected for common MR T1 weighted imaging artifacts, which can undermine segmentation accuracy, by an experienced researcher (WH Shim) and neuroradiologist (HM Yoon).

2.3. Image analyses {#s0025}
-------------------

All measurements, including cortical thickness, surface area, and volume were obtained from T1 MRI scans using FreeSurfer (version 5.3.0, <https://surfer.nmr.mgh.harvard.edu>), a fully automated surface-based analysis. The technical details of the procedures have been previously described ([@bb0030], [@bb0060], [@bb0055], [@bb0065]). Briefly, the processing pipeline included correcting of intensity variation, removal of non-brain tissue, segmentation of the gray matter/white matter (GM/WM) tissue, tessellation of the cortical GM/WM boundary, inflation of the folded surfaces, and automatic correction of topological defects to detect GM/WM and GM/cerebrospinal fluid (CSF) boundaries. Cortical thickness was quantified as the closest distance from the GM/WM boundary to the GM/CSF boundary at each vertex. Subcortical volumes were calculated with FreeSurfer\'s automated procedure for volumetric measures. Each voxel in the normalized brain volumes were assigned to one of 40 labels, including cerebellum and brain stem ([@bb0065]). Cortical volume, cortical thickness, and surface area were estimated for 34 regions per hemisphere according to the Desikan FreeSurfer atlas ([@bb0040]). To improve accuracy of imaging analysis, key intermediate processing outputs (skull stripping, segmentation, parcellation) of FreeSurfer were visually inspected and, if needed, brain masks and inaccurate definitions of white matters were manually corrected by a trained researcher (WH Shim) as described in FreeSurfer website.[3](#fn0015){ref-type="fn"}

2.4. Statistical analyses {#s0030}
-------------------------

We compared age and gender distributions between groups using *t*-tests and chi-square tests. FreeSurfer\'s built-in general linear model tool, QDEC, was performed to compare regional cortical thickness between groups, controlling for age and gender. Cortical thickness data were smoothed with a 10 mm full width at half maximum (FWHM) Gaussian kernel. To correct for multiple comparisons, the false discovery rate (FDR) was implemented using a cluster-wise correction method with an initial cluster-forming threshold set at *p* \< 0.01. Only clusters with a corrected value of *p* \< 0.05 were considered to be significant. Analysis of covariance (ANCOVA) was performed using SPSS version 18.0 (SPSS, Chicago, IL) to compare group differences in the mean cortical thickness, mean surface area, and volume (global volume and regional volume) with age and gender as covariates. In surface area and volumetric analysis, total intracranial volume (TIV) was included as a covariate to control the total brain size. Bonferroni correction for multiple comparisons was applied, and a *p* \< 0.0015 was considered to be significant for both the cortical volume and surface area analysis for 34 regions (*p* \< 0.05/34) as well as the analysis of 35 subcortical structural volumes (*p* \< 0.05/35). We also assessed age-related group differences using QDEC (cortical thickness) and ANCOVA in SPSS (volume, surface area) after adjusting age and gender. The measurements in whole-brain analysis and age-related group differences were considered as significant with a value of *p* \< 0.05.

3. Results {#s0035}
==========

3.1. Demographical and clinical characteristics {#s0040}
-----------------------------------------------

A total of 21 patients and 42 healthy control subjects were recruited. All demographic and clinical characteristic data from the patient and healthy control groups are shown in [Table 1](#t0005){ref-type="table"} and [Inline Supplementary Table S1](#b0005){ref-type="boxed-text"}.Table 1Demographic data of patient and control group.Table 1Patient groupControl group*p*-ValueNumber of subjects, n2142Age (months), mean ± SD57.8 ± 30.159.1 ± 29.80.878Sex (male)7 (33.3%)14 (33.3%)1.0Age at seizure onset (months), mean ± SD8.1 ± 7.8----Status epilepticus, n (%)11 (52.4%)----Psychomotor status, n (%)---- Normal intelligence3 (14.3%) Mild mental retardation8 (38.1%) Moderate mental retardation8 (38.1%) Severe mental retardation2 (9.5%) Ataxia, n (%)4 (19%)----

Inline Supplementary Table S1Inline Supplementary Table S1Table S1Clinical and demographic data of patient group.Table S1Case no.SexAge at MRI (mon)Age at seizure onset (mon)Initial seizure typeAssociating factorOther seizure typeSECognitive and behavioral outcomeResistance to multiple AED[a](#tf0025){ref-type="table-fn"}Ataxia*SCN1A* mutation1F273.8CPSFeverAtypical absence, focal motor, 2ndary GTCsYModerate MRYNc.G5596A\
p.Asp1866Asn2F5337.5GTCsFeverMyoclonic seizureYModerate MRYNc.1630delA\
p.Thr544HisfsX143F406.6Focal motor seizureUKAtypical absence, focal motor, tonic, 2ndary GTCsYModerate MRYNc.602 + 1G \> C4M854.5CPSUKHemiclonic, 2ndary GTCs, myoclonic, absence seizureNSevere MRYNc.C1088G\
p. Thr363Arg5F244.8Focal motor seizureFeverFocal motor, 2ndary GTCs, CPS, myoclonic, tonic seizureYModerate MRYNc.1212A \> G,\
c.2292 T \> C6F1043.6CPSFever2ndary GTCs, tonic seizureYMild MRNNc.C479A\
p.Thr160Asn7M2915.9GTCsFeverNoneNNormal until 2.4yrUKNc.1217T \> G p.Val406Gly8M305.3GTCsFeverNoneNMild MRYNc.3598T \> C p.Cys1200Arg9F342.5Hemiclonic seizureFeverCPS, 2ndary GTCs, tonic seizureYMild MRYNc.4188C \> A\
p.Cys1396X10F126UKUKFeverGTCs, CPSNNormal until 10 yrYNc.2911G \> A p.Val971lle11F765.0GTCsFeverCPSYModerate MRYNc.3340_3343del p.Thr1114TyrfsX512F7814.7UKFeverCPS, GTCs,YMild MRYNc.1129C \> T\
p.Arg377Tre13F409.8UKFeverCPSYNormal until 2.8 yrNNc.4096G \> A\
p.Val13661le14F888.0UKFeverCPS, 2ndary GTCsYMild MRYNc.1549G \> T\
p.Glu517X15F329.9GTCsFever2ndaryGTCs,\
myoclonic, CPS, atypical absenceNMild MRYYc.4216G \> A\
p.Ala1406Thr16F386.7GTCsFever2ndary GTC, CPS, tonic seizureNMild MRYNc.2854T \> C p.Trp952Arg17M525.3GTCsFever2ndary GTC, focal clonic, CPSNMild MRYNc.3946A \> T p.Arg1316Trp18M857.7GTCsFever2ndary GTC, myoclonic, atypical absence, focal motor, tonicNModerate MRYYc.3160C \> T p.Gln1036X19M425.2CPSFeverAtypical absence, myoclonic, CPS,2ndary GTC, focal motorNModerate MRYYc.4488delA\
p.Asp1497ThrfsX420F383.0Hemiclonic seizureFeverCPS, 2ndary GTC, myoclonic seizureYMild MRYYc.4539dupA\
p.Leu1514IlefsX2321M962.8Hemiclonic seizureFever, vaccinationFocal clonic, 2ndary GTC, CPSNModerate MRYNc.596_602 + 3del\
p.Thr199SerfsX15[^3][^4]

3.2. Whole-brain analysis {#s0045}
-------------------------

There was no significant difference in the total intracranial volume (TIV) between the two groups (*p* = 0.09). After controlling for age, sex, and TIV, the total brain, total GM, total cortical GM, subcortical GM, total cortical WM, and cerebellar WM, total cerebellar volumes of the patient group were significantly smaller than those of the healthy control group, while the cerebellar GM was not different ([Table 2](#t0010){ref-type="table"}). The mean cortical surface area and cortical thickness were significantly reduced in the patient group, with a much larger discrepancy in surface area (difference between means: − 5.5%, *p* \< 0.001) than in cortical thickness (difference between means: − 2.4%, *p* = 0.045).Table 2Whole-brain analysis.Table 2MeasurementPatient groupControl group*p*-Value [a](#tf0005){ref-type="table-fn"}Difference between means (%)Total brain volume1,010,403 ± 74251,061,252 ± 10,586\<** 0**.**001**− 4.8Total GM volume659,426 ± 7990695,315 ± 5604\<** 0**.**001**− 5.2Total cortical GM volume507,927 ± 6866543,168 ± 4816\<** 0**.**001**− 6.5Subcortical GM volume52,331 ± 85655,539 ± 601**0**.**004**− 5.8Total cortical WM volume330,133 ± 49,997342,700 ± 3505**0**.**046**− 3.7Cerebellar WM volume21,226 ± 66923,800 ± 470**0**.**003**− 10.8Cerebellar GM volume99,844 ± 205497,836 ± 14400.43+ 2.0Total cerebellum volume121,070 ± 2289121,636 ± 1605**0**.**040**− 0.5Mean surface area151,530 ± 1923160,271 ± 1349\<** 0**.**001**− 5.5Mean cortical thickness2.83 ± 0.032.90 ± 0.02**0**.**045**− 2.4[^5][^6][^7][^8][^9]

3.3. Effect of age on volume, cortical thickness and surface area {#s0050}
-----------------------------------------------------------------

We compared the age effect on cortical thickness, global volume and surface area between the two groups. In comparison with the control group, there was no observed statistically significant difference in terms of age effect on total brain (*p* = 0.056), total GM (*p* = 0.076), total cortical GM (*p* = 0.077), total cortical WM (*p* = 0.097), cerebellar WM (*p* = 0.276) and cerebellar GM volume (*p* = 0.192), mean cortical thickness (*p* = 0.344) and mean surface area (*p* = 0.134). ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1Linear correlations between age and global volume in the patient and control groups.Fig. 1

The scatter plots show the age effect on total brain volume (A), total cortical gray matter volume (B), total gray matter volume (C), and total cortical white matter volume (D). CM, control male group; CF, control female group; PM, patient male group; PF, patient female group.

3.4. Subcortical volume analysis {#s0055}
--------------------------------

Subcortical volume analysis was performed to compare the volumes of the subcortical structures (thalamus, caudate, putamen, pallidum, hippocampus, accumbens area, CSF, and corpus callosum), cerebellum, and brainstem between the patient and control groups. After correction for multiple comparisons, the patient group showed significantly reduced volumes in bilateral putamen, caudate, accumbens area compared to the control group (corrected *p*-value \< 0.05) ([Table 3](#t0015){ref-type="table"}).Table 3Group comparison of subcortical volume analysis.Table 3Subcortical volumePatient groupControl group*p*-Value[a](#tf0010){ref-type="table-fn"}, [⁎](#tf0015){ref-type="table-fn"}Difference between means (%)Putamen L5213 ± 167.95994 ± 117.8\< 0.001− 13.0 R5248 ± 164.86002 ± 115.6\< 0.001− 12.6Caudate L3274 ± 88.03663 ± 61.7\< 0.001− 10.6 R3276 ± 90.33688 ± 63.3\< 0.001− 11.2Accumbens area L557 ± 33.6703 ± 23.6\< 0.001− 20.8 R579 ± 34.4736 ± 24.1\< 0.001− 21.3[^10][^11][^12][^13][^14]

3.5. Regional analysis of volume, surface area, cortical thickness {#s0060}
------------------------------------------------------------------

After correction for multiple comparisons, a regional surface area analysis of 34 parcellated regions per hemisphere found that patients had significantly decreased surface areas in the left lateral orbitofrontal and right middle temporal area ([Table 4](#t0020){ref-type="table"}). Also, the patient group showed a significantly smaller GM volume in the bilateral inferior parietal, left lateral orbitofrontal, left precentral, right postcentral, right isthmus cingulate, right middle temporal areas ([Table 4](#t0020){ref-type="table"}). In the regional WM volume analysis, the patient group showed a significantly smaller WM volume in the left lateral orbitofrontal area. There was no area where patients group showed statistically significant difference in regional cortical thickness analysis. Regional morphometric findings are described in more detail in the [Inline Supplementary Table S2](#b0010){ref-type="boxed-text"}.Table 4Group comparison of surface area, gray matter and white matter volume in 34 parcellated regions.Table 4Parcellated regionSurface area[a](#tf0020){ref-type="table-fn"}GM volume[a](#tf0020){ref-type="table-fn"}WM volume[a](#tf0020){ref-type="table-fn"}LeftRightLeftRightLeftRightFrontal Superior frontal0.0580.0270.0290.0030.2690.019 Rostral middle frontal0.0430.1900.0610.0280.1260.455 Caudalmiddle frontal0.2870.3020.2160.1220.9330.224 Pars opercularis0.1110.3960.1160.1890.0470.476 Pars triangularis0.0060.0200.0050.0090.0090.141 Pars orbitalis0.0020.0340.0290.0040.0290.150 Lateral orbitofrontal\<** 0**.**001**0.082\<** 0**.**001**0.464\<** 0**.**001**0.033 Medial orbitofrontal0.1890.0520.2940.1060.9590.089 Precentral0.0140.728**0**.**001**0.0230.6110.343 Paracentral0.0070.6770.0020.2440.2430.443 Frontal pole0.2030.0970.2940.1210.5970.061 Rostral anterior cingulate0.0740.0760.0300.2800.9460.494 Caudal anterior cingulate0.1740.1630.1840.0380.2360.451Parietal Superior parietal0.5620.5830.0490.0580.5480.410 Inferior parietal0.0020.002\<** 0**.**001**\<** 0**.**001**0.0020.043 Supramarginal0.7130.0250.2810.0060.4880.272 Postcentral0.5480.0060.008\<** 0**.**001**0.9980.059 Precuneus0.0950.0030.0160.0020.0980.008 Posterior cingulate0.0020.2330.0100.2480.0350.486 Isthmus cingulate0.0070.0110.040\<** 0**.**001**0.0380.801Temporal Superior temporal0.0670.0110.1680.0200.7000.461 Middle temporal0.032\<** 0**.**001**0.232\<** 0**.**001**0.7360.035 Inferior temporal0.0020.1230.0170.8510.0160.071 Banks of the STS0.2400.0140.0990.0150.2670.040 Fusiform0.0030.1910.0410.4760.0050.062 Transverse temporal0.9580.4640.1280.0890.5840.154 Entorhinal0.3200.8440.5740.8110.5850.649 Temporal pole0.0390.5080.9280.1730.6230.814 Parahippocampal0.1550.5060.0030.0360.0660.504Occipital Lateral occipital0.2200.1800.0420.0710.8780.974 Lingual0.2340.5470.3760.4320.3020.813 Cuneus0.0170.2560.0140.0080.1420.543 Pericalcarine0.1930.4920.2590.0420.4740.462Insular cortex0.0810.6300.2150.3910.1940.817Unsegmented WM0.0380.075[^15][^16][^17]

Inline Supplementary Table S2Inline Supplementary Table S2Table S2Measurementsof surface area, gray matter volume and white matter volume in 34 parcellated regions.Table S2Parcellated regionsSurface area[a](#tf0030){ref-type="table-fn"}Gray matter volume[a](#tf0030){ref-type="table-fn"}White matter volume[a](#tf0030){ref-type="table-fn"}PatientControlPatientControlPatientControlFrontal Superior frontalL6224.5 ± 108.66484.0 ± 76.124110.2 ± 463.125392.0 ± 324.812655.7 ± 245.013392.4 ± 171.8R5932.0 ± 98.46205.8 ± 69.022669.8 ± 426.024290.3 ± 298.812655.7 ± 245.013392.4 ± 171.8 Rostral middlefrontalL4998.8 ± 108.15274.8 ± 75.817869.0 ± 416.118849.0 ± 291.89519.8 ± 262.010021.4 ± 183.8R5221.9 ± 130.55419.0 ± 84.518572.6 ± 436.319787.8 ± 306.19908.5 ± 240.910132.2 ± 169.0 Caudal middle frontalL2034.9 ± 74.62134.0 ± 52.46508.9 ± 233.36869.0 ± 163.65143.4 ± 178.75162.0 ± 125.3R1832.6 ± 61.91912.2 ± 43.45931.1 ± 246.06407.7 ± 172.64223.3 ± 145.74444.5 ± 102.2 Pars opercularisL1431.8 ± 48.11527.8 ± 33.75104.1 ± 171.55442.1 ± 120.32572.3 ± 98.12817.6 ± 68.8R1255.7 ± 50.11308.5 ± 35.14400.7 ± 166.84674.6 ± 117.02500.6 ± 106.12594.7 ± 74.4 Pars triangularisL12067.9. ± 40.91212.1 ± 28.73871.8 ± 155.04433.6 ± 108.72137.2 ± 70.22372.4 ± 49.2R1285.1 ± 39.51401.7 ± 27.74702.1 ± 155.25220.0 ± 108.92432.3 ± 72.92566.6 ± 51.1 Pars orbitalisL496.7 ± 13.3550.6 ± 9.32343.4 ± 78.02558.5 ± 54.7615.2 ± 17.6663.9 ± 12.4R632.7 ± 18.2681.5 ± 12.72812.5 ± 92.63154.2 ± 65.0809.5 ± 26.1856.4 ± 18.3 Lateral orbitofrontalL**2022**.**8** ± **50**.**92271**.**9** ± **35**.**77621**.**9** ± **172**.**48470**.**8** ± **120**.**94557**.**3** ± **107**.**65030**.**3** ± **75**.**4**R2092.6 ± 44.12189.2 ± 31.0**7833**.**0** ± **205**.**58020**.**2** ± **144**.**2**4681.7 ± 93.64934.4 ± 65.7 Medial orbitofrontalL1482.5 ± 40.51549.0 ± 28.45562.5 ± 151.35760.4 ± 106.12524.6 ± 95.32530.7 ± 66.8R1512.9 ± 42.21616.1 ± 29.65785.8 ± 147.46084.5 ± 103.42653.6 ± 65.42793.2 ± 45.9 PrecentralL4452.4 ± 105.44781.0 ± 73.9**13531**.**4** ± **293**.**814751**.**5** ± **206**.**1**9802.4 ± 194.39679.7 ± 136.3R4613.1 ± 133.54670.6 ± 93.613460.4 ± 359.714495.4 ± 252.310350.1 ± 268.810033.1 ± 188.6 ParacentralL1163.7 ± 38.71297.9 ± 27.23656.6 ± 145.44241.0 ± 102.02800.0 ± 95.12938.4 ± 66.7R1417.9 ± 50.31443.9 ± 35.34416.4 ± 185.44685.7 ± 130.03702.7 ± 126.23582.3 ± 88.5 Frontal poleL202.6 ± 7.0212.7 ± 3.51079.0 ± 50.91045.6 ± 35.7191.9 ± 7.3196.7 ± 5.1R265.0 ± 7.6280.8 ± 5.31394.6 ± 47.21486.4 ± 33.1246.8 ± 11.5273.9 ± 8.1 Rostral anterior cingulateL638.0 ± 25.5695.4 ± 17.92633.4 ± 114.12946.7 ± 80.12262.5 ± 66.02268.0 ± 46.3R507.8 ± 27.8569.9 ± 19.52175.4 ± 110.72324.4 ± 77.71737.9 ± 64.81793.0 ± 45.5 Caudal anterior cingulateL528.1 ± 23.0567.1 ± 16.11810.7 ± 90.81961.3 ± 63.72387.7 ± 79.92505.9 ± 56.0R664.4 ± 40.1721.1 ± 40.12252.7 ± 127.52587.4 ± 89.52599.4 ± 97.12690.3 ± 68.1Parietal Superior parietalL5378.3 ± 132.15473.5 ± 92.615548.1 ± 448.816661.9 ± 314.89869.4 ± 223.09702.9 ± 156.4R5188.8 ± 118.15269.2 ± 82.815087.6 ± 429.316114.1 ± 301.19174.4 ± 222.37946.6 ± 155.9 Inferior parietalL4345.0 ± 99.94737.7 ± 70.0**14577**.**6** ± **414**.**216865**.**8** ± **290**.**6**7784.1 ± 213.08485.4 ± 149.4R4869.9 ± 142.85429.3 ± 100.2**16867**.**0** ± **488**.**819283**.**8** ± **342**.**9**8833.6 ± 282.69555.1 ± 198.2 SupramarginalL3764.2 ± 92.93806.7 ± 65.113003.1 ± 370.413500.7 ± 259.87030.5 ± 172.56882.0 ± 121.0R3422.3 ± 75.83637.0 ± 53.211549.9 ± 316.112668.3 ± 221.76821.3 ± 188.57079.2 ± 132.2 PostcentralL4164.2 ± 99.94234.8 ± 70.110997.4 ± 290.011988.6 ± 203.45843.1 ± 174.45842.5 ± 122.3R3869.3 ± 102.54232.9 ± 71.9**10229**.**7** ± **329**.**211824**.**5** ± **230**.**9**5656.2 ± 150.06013.4 ± 105.2 PrecuneusL3608.6 ± 92.93803.4 ± 65.211666.7 ± 324.012658.0 ± 227.37108.2 ± 186.27495.0 ± 130.6R3572.6 ± 91.53917.5 ± 64.211412.9 ± 333.312739.9 ± 233.87318.9 ± 184.47948.6 ± 129.3 Posterior cingulateL1015.2 ± 31.11138.6 ± 21.83451.1 ± 121.93849.8 ± 85.53526.1 ± 87.13758.4 ± 61.1R1130.4 ± 39.31188.9 ± 27.63774.1 ± 141.13977.4 ± 99.03704.0 ± 189.03798.3 ± 76.4 Isthmus cingulateL912.5 ± 28.71011.3 ± 20.13100.2 ± 83.73317.3 ± 58.73068.6 ± 83.23286.6 ± 58.4R866.0 ± 22.0937.4 ± 15.4**2789**.**8** ± **79**.**33148**.**7** ± **55**.**6**2793.2 ± 83.82819.3 ± 58.7Temporal Superior temporalL3357.5 ± 64.73506.6 ± 45.412486.9 ± 322.613043.5 ± 226.35862.6 ± 113.65926.5 ± 93.7R3264.4 ± 60.13458.6 ± 42.112431.9 ± 254.413185.9 ± 178.45141.6 ± 114.65246.6 ± 80.4 Middle temporalL2614.3 ± 68.22798.8 ± 47.811598.4 ± 285.912024.2 ± 200.54106.3 ± 127.54159.6 ± 89.4R**2862**.**5** ± **64**.**33162**.**2** ± **45**.**112346**.**0** ± **286**.**813599**.**6** ± **201**.**2**4613.9 ± 127.54952.8 ± 89.4 Inferior temporalL2710.1 ± 92.83074.5 ± 65.110018.2 ± 352.111086.2 ± 246.64566.8 ± 166.15074.5 ± 116.5R2670.4 ± 75.12815.6 ± 52.710224.6 ± 347.210305.2 ± 243.54393.9 ± 109.54642.1 ± 76.8 Banks of the superior temporal sulcusL889.5 ± 34.8940.5 ± 24.42568.0 ± 121.42819.1 ± 85.22199.6 ± 111.22353.4 ± 78.0R801.3 ± 31.5899.9 ± 22.12424.9 ± 106.42754.3 ± 74.62019.7 ± 100.72281.2 ± 70.6 FusiformL2758.5 ± 86.03086.5 ± 60.410023.5 ± 366.610971.8 ± 257.14748.8 ± 132.55411.8 ± 92.9R2818.4 ± 72.92937.3 ± 51.110097.6 ± 293.810357.7 ± 206.14913.3 ± 111.85176.0 ± 78.4 Transverse temporalL440.0 ± 15.0441.1 ± 10.51371.2 ± 54.21474.5 ± 38.1612.9 ± 26.4630.8 ± 18.5R328.8 ± 10.9338.7 ± 7.61063.8 ± 44.71159.4 ± 31.4564.2 ± 22.3524.4 ± 15.7 EntorhinalL334.9 ± 14.1352.3 ± 9.91614.4 ± 66.41660.7 ± 46.6578.8 ± 34.4602.2 ± 24.1R286.1 ± 14.2289.6 ± 9.91493.8 ± 84.21468.8 ± 59.0439.5 ± 24.9435.5 ± 17.5 Temporal poleL426.1 ± 12.3458.1 ± 8.62615.0 ± 102.32626.4 ± 71.8603.9 ± 22.0589.7 ± 15.4R384.3 ± 12.0394.1 ± 8.42439.4 ± 108.52254.5 ± 76.1537.3 ± 19.2542.9 ± 13.5 ParahippocampalL648.8 ± 28.2698.9 ± 19.82019.0 ± 91.92373.7 ± 64.51170.4 ± 94.51388.9 ± 66.3R606.1 ± 18.1621.1 ± 12.71907.7 ± 58.72063.2 ± 41.21285.6 ± 63.71338.4 ± 44.6Occipital Lateral occipitalL4425.7 ± 94.14569.6 ± 65.912183.7 ± 297.812946.3 ± 208.96793.8 ± 188.56558.0 ± 132.2R4255.1 ± 117.74452.4 ± 82.611929.5 ± 481.513022.4 ± 337.76563.3 ± 216.66554.5 ± 151.9 LingualL2771.9 ± 98.72918.5 ± 69.37566.7 ± 312.07910.1 ± 218.84222.7 ± 169.84441.0 ± 119.2R2786.7 ± 79.32846.0 ± 55.67574.9 ± 258.98048.5 ± 128.24394.8 ± 140.14353.8 ± 98.2 CuneusL1271.0 ± 42.91401.0 ± 30.13334.8 ± 123.03721.0 ± 86.31689.8 ± 61.71803.2 ± 43.3R1413.6 ± 34.11416.9 ± 23.93613.3 ± 112.33996.3 ± 78.81829.6 ± 60.41783.9 ± 42.4 PericalcarineL1210.2 ± 51.71294.2 ± 36.32283.6 ± 132.12468.4 ± 92.62151.8 ± 107.72247.6 ± 75.5R1413.0 ± 47.61453.7 ± 33.42470.5 ± 111.52757.3 ± 78.22418.2 ± 98.42328.2 ± 69.0Insular cortexL1837.5 ± 35.91916.3 ± 10.56620.7 ± 127.66818.1 ± 89.56977.1 ± 151.57028.9 ± 106.3R1859.2 ± 38.11881.9 ± 26.76646.0 ± 119.16772.9 ± 83.57073.1 ± 130.87035.5 ± 94.0Unsegmented WML16165.2 ± 663.417241.0 ± 465.3R16654.9 ± 650.218108.5 ± 456.0[^18][^19][^20][^21]

4. Discussion {#s0065}
=============

This study aimed to investigate morphometric brain abnormalities in patients with *SCN1A* mutation and related epilepsy. In the whole-brain analysis, we found significantly smaller total brain volume, total cortical GM volume, subcortical GM volume, total cortical WM volume and cerebellar WM volume in the patient group compared to the control group. These volume changes are consistent with previous studies, suggesting non-specific neuroimaging findings, such as atrophic change on cerebral and cerebellar area ([@bb0015], [@bb0085], [@bb0160]) and brain morphometry analysis in patients with Dravet syndrome ([@bb0130]). Although the potential mechanism responsible for the volume change is uncertain, functional changes in GABAergic inhibitory interneurons, which are important in normal brain development, can alter the neural network formation ([@bb0075]). One report also supports this hypothesis in that it has identified progressively reduced dendritic arborization and excessive spines in dentate gyrus granule cell of the mouse model (*Scn1a*^E1099X/+^) mimicking human Dravet syndrome ([@bb0180]). This same study supports that this microstructural alteration likely results in neural network instability and has an impact on epileptogenesis and higher-order cognitive processing.

In our study, we identified brain developmental patterns in epileptic children with *SCN1A* mutation, which has not previously been shown by routine visual analysis. While patient group exhibited similar trajectories of global brain development of the normal controls, the total brain volume, GM and WM volume showed the largest discrepancy between the patients and controls during early childhood ([Fig. 1](#f0005){ref-type="fig"}). There is robust growth in human brain volume, mainly in the gray matter, through the first 2 years of life, with rapid elaboration of dendrites, spines, and synapses ([@bb0165]). Synaptic overgrowth in early infancy is essential to ensure the complete wiring of the nervous system ([@bb0175]). Smaller GM volume during early childhood of patients with *SCN1A* mutation may be related to insufficient synaptogenesis and myelination in first 2 years of age, as well as an abnormal cortical pruning process through childhood ([@bb0165]).

In our study, we also identified a smaller subcortical volume in the bilateral areas of putamen, caudate, accumbens area in the patients group compared to control group. The basal ganglia neural circuit connected with the cortex and the thalamus plays a key role in the modulation of motor control as well as cognitive and executive function and behavior ([@bb0010]). The significant subcortical volume changes observed in this study could explain the epileptic seizures, motor impairments and cognitive declines of Dravet syndrome ([@bb0045]).

In the regional analysis, the patient group exhibited a smaller GM volume in the bilateral inferior parietal, left lateral orbitofrontal, left precentral, right postcentral, right isthmus cingulate, right middle temporal area with the reduced surface area and WM volume in some of these areas. The inferior parietal, isthmus cingulate, and the middle temporal gyrus comprise the default mode network that influences task performance and the integration of cognitive and emotional processing ([@bb0135]). These structural changes may be related to the widespread alteration of the neuronal network related to epilepsy in patients with *SCN1A* mutation. Previous report also showed activation in areas of the default mode network in patients with Dravet syndrome ([@bb0115]). The lateral orbitofrontal cortex is involved in guiding stimulus based learning and decision making ([@bb0190]) and the middle temporal gyrus is involved in a number of cognitive processes, including semantic memory processing, language processes, as well as visual perception and multimodal sensory integration ([@bb0035], [@bb0105]). The pre- and post-ercentral areas interact to generate somatosensory and motor function ([@bb0120]). The higher incidence of learning difficulties, language delays, motor impairment and behavior disorders in patient with *SCN1A* mutation-related epilepsy ([@bb0045], [@bb0200]) can be explained by the reduced size of these areas, which in turn may cause the malfunction of these structures. Conversely, previous brain morphometric analysis in patients with Dravet syndrome revealed no difference in local GM volume ([@bb0130]). This discrepancy could be explained differences in the tools used for analysis and/or characteristics of the enrolled patients, such as the inclusion of younger patient groups irrespective of disease severity. As we noted, the younger patients showed a bigger difference in volume in this study ([Fig. 1](#f0005){ref-type="fig"}). However, present study could not clarify exact neuro-anatomical pattern correlated with phenotype since this study included too young patients (mean age at last follow up: 7.7 ± 2.9 years) to define the clinical diagnosis such as Dravet syndrome or GEFS +. Further study with larger patient group will be required to find the stratified results according to the phenotype.

Cortical volume is composed of two independent components, surface area and cortical thickness, which have different ontogenic processes from one another, providing independent information on brain development ([@bb0185]). While cortical thickness depends on the numbers of cells in their intrinsic radial column, surface area is associated with the number of radial columns which can be affected by the inputs from subcortical structures ([@bb0140]). Also, the volume is more highly correlated with area because volume is a quadratic function of surface distance and only a linear function of thickness ([@bb0195]). In our study, patient group exhibited a much larger discrepancy in mean surface area than mean cortical thickness. Also, most of the regions with reduced GM volume were consistent with the region with smaller surface area in the patient group, while the cortex was not significantly thinner in the patient group than the control group according to the regional cortical thickness analysis. This result is in agreement with previous study suggesting that cortical thickness and surface area were found to be genetically independent ([@bb0195]). The genetic influence of the *SCN1A* mutation may affect separately on cortical thickness and surface area during ontogenic processes.

Additionally, cerebellar WM volume was significantly smaller in patients with *SCN1A* mutations. The cerebellum is involved in motor coordination, balance, and posture, as well as in cognitive functions, such as memory, language, visuospatial skills, and attention ([@bb0170], [@bb0050]). An experimental mouse model of Dravet syndrome revealed that the impairment of the sodium current and action potential firing in the GABAergic Purkinje neurons of the cerebellum may be responsible for motor coordination ([@bb0095]) and that Purkinje neurons play an important role in cerebellar development and maturation ([@bb0070]). Thus, the core symptoms of Dravet syndrome, including ataxia, poor motor coordination, and autistic behavior, can be explained by these changes to the cerebellum linked to *SCN1A* mutation ([@bb0045], [@bb0005]).

This study has some limitations due to its small sample size and study design in that it is a cross-sectional study and may reflect cohort differences rather than true developmental trajectories. Furthermore, this study only examined linear age effects and interactions exclusively in patients 2--12 years of age, despite the fact that key cortical measures, such as cortical thickness, have been shown to have non-linear developing trajectory through their life ([@bb0155]). Technically, the subjects have been scanned on two different scanners with different parameters, which may influence the GM segmentation. However, all data used in our study were carefully visually inspected by a trained researcher, which may result in more reliable estimates ([@bb0090]). Another limitation is the heterogeneity in patient characteristics in terms of frequency of seizures, developmental status, and genetic subtypes, which may be possible confounding factors. In the future, longitudinal studies with larger sample sizes and wider age ranges should be conducted to detect more accurate developmental trajectories after stratification by patient characteristics.

5. Conclusions {#s0070}
==============

Using surface-based morphometric analysis, we found large-scale structural brain alterations associated with *SCN1A* mutation and related epilepsy, which may be linked to the core symptoms of *SCN1A* mutation-positive epilepsy. Children with *SCN1A* mutation-positive epilepsy showed smaller cortical and subcortical GM and surface area and exhibited changes in developmental trajectory compared to healthy control patients. Future longitudinal and in vivo functional studies of *SCN1A* mutation are needed to confirm the effect of *SCN1A* gene mutation on structural brain development.
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